Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01452906 · ClinicalTrials.gov registry record · Phase 1
A Drug-Drug Interaction Study of Omeprazole and PA21
A Phase 1 study, sponsored by Vifor Pharma.
- Completed
- Registry status
- Phase 1
- Development phase
- 45
- Enrollment target
NCT01452906 is a Phase 1 study that has completed, run by Vifor Pharma. The registered enrollment target is 45 participants.
The verdict
NCT01452906, a Phase 1 study, has completed, sponsored by Vifor Pharma.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if Omeprazole is affected by PA21.
Interventions
- DRUG PA21 and Omeprazole with food
- DRUG No PA21; Omeprazole with food
- DRUG PA21 with food, Omeprazole 2hrs later
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2011-09 |
| Est. Completion | 2011-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01452906
The ClinicalTrials.gov registry entry for NCT01452906 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vifor Pharma, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which PA21 and Omeprazole with food is the first listed.
NCT01452906 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01452906 about?
NCT01452906 is a clinical study titled "A Drug-Drug Interaction Study of Omeprazole and PA21". The purpose of this study is to determine if Omeprazole is affected by PA21.
What is the current status of trial NCT01452906?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 45 participants. The study started on 2011-09. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01452906?
The interventions under investigation include: PA21 and Omeprazole with food (DRUG), No PA21; Omeprazole with food (DRUG), PA21 with food, Omeprazole 2hrs later (DRUG).
Who is sponsoring clinical trial NCT01452906?
This trial is sponsored by Vifor Pharma, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.